JP6047172B2 - 患者部分集団における痛風の治療方法 - Google Patents

患者部分集団における痛風の治療方法 Download PDF

Info

Publication number: JP6047172B2
Authority: JP; Japan
Prior art keywords: uric acid; gout; subject; compound; oral
Prior art date: 2011-11-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

JP2014541012A

Other languages

English (en)

Japanese (ja)

Other versions

JP2014532759A5 (he

JP2014532759A (ja

Inventor

ゴパール・チャンドラ・サハ

ブライアン・ケイ・ロバーツ

ブライアン・エドワード・ラバン

チャールズ・エイ・マックウェーター

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

CymaBay Therapeutics Inc

Original Assignee

CymaBay Therapeutics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-11-04

Filing date

2011-11-04

Publication date

2016-12-21

2011-11-04 Application filed by CymaBay Therapeutics Inc filed Critical CymaBay Therapeutics Inc

2014-12-08 Publication of JP2014532759A publication Critical patent/JP2014532759A/ja

2015-01-22 Publication of JP2014532759A5 publication Critical patent/JP2014532759A5/ja

2016-12-21 Application granted granted Critical

2016-12-21 Publication of JP6047172B2 publication Critical patent/JP6047172B2/ja

Status Expired - Fee Related legal-status Critical Current

2031-11-04 Anticipated expiration legal-status Critical

Images

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Diabetes (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

JP2014541012A 2011-11-04 2011-11-04 患者部分集団における痛風の治療方法 Expired - Fee Related JP6047172B2 (ja)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US2011/059425 WO2013066352A1 (en)	2011-11-04	2011-11-04	Methods for treating gout in patient subpopulations

Publications (3)

Publication Number	Publication Date
JP2014532759A JP2014532759A (ja)	2014-12-08
JP2014532759A5 JP2014532759A5 (he)	2015-01-22
JP6047172B2 true JP6047172B2 (ja)	2016-12-21

Family

ID=48192536

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2014541012A Expired - Fee Related JP6047172B2 (ja)	2011-11-04	2011-11-04	患者部分集団における痛風の治療方法

Country Status (14)

Country	Link
EP (1)	EP2775835A4 (he)
JP (1)	JP6047172B2 (he)
KR (1)	KR101848122B1 (he)
CN (1)	CN104066323A (he)
AU (1)	AU2011380509B2 (he)
BR (1)	BR112014010693A2 (he)
CA (1)	CA2859689C (he)
CL (1)	CL2014001156A1 (he)
IL (1)	IL232385A (he)
MX (1)	MX354846B (he)
NZ (1)	NZ624714A (he)
SG (1)	SG11201402027PA (he)
WO (1)	WO2013066352A1 (he)
ZA (1)	ZA201403574B (he)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EA028495B1 (ru) *	2012-04-13	2017-11-30	Саймабэй Терапьютикс, Инк.	Пероральная композиция для лечения подагры на основе (-)-галофената и колхицина
CN104068288B (zh) *	2014-07-25	2016-08-24	许伟琦	一种防尿路结石的饲料添加剂
CN105920022A (zh) *	2016-05-12	2016-09-07	成都易创思生物科技有限公司	一种抗痛风药物复方制剂
EP3701952A4 (en) *	2017-10-26	2021-06-30	Otsuka Pharmaceutical Co., Ltd.	INOSITE PHOSPHATE COMPOSITION

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4250191A (en) *	1978-11-30	1981-02-10	Edwards K David	Preventing renal failure
US6262118B1 (en) *	1999-06-04	2001-07-17	Metabolex, Inc.	Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
AU2008329673C1 (en) *	2007-11-27	2012-10-25	Ardea Biosciences, Inc.	Novel compounds and compositions and methods of use

2011
- 2011-11-04 MX MX2014005399A patent/MX354846B/es active IP Right Grant
- 2011-11-04 KR KR1020147015209A patent/KR101848122B1/ko not_active Expired - Fee Related
- 2011-11-04 AU AU2011380509A patent/AU2011380509B2/en not_active Ceased
- 2011-11-04 NZ NZ624714A patent/NZ624714A/en not_active IP Right Cessation
- 2011-11-04 SG SG11201402027PA patent/SG11201402027PA/en unknown
- 2011-11-04 JP JP2014541012A patent/JP6047172B2/ja not_active Expired - Fee Related
- 2011-11-04 BR BR112014010693-2A patent/BR112014010693A2/pt not_active IP Right Cessation
- 2011-11-04 EP EP11875027.2A patent/EP2775835A4/en not_active Withdrawn
- 2011-11-04 WO PCT/US2011/059425 patent/WO2013066352A1/en active Application Filing
- 2011-11-04 CA CA2859689A patent/CA2859689C/en not_active Expired - Fee Related
- 2011-11-04 CN CN201180076189.7A patent/CN104066323A/zh active Pending
2014
- 2014-04-30 IL IL232385A patent/IL232385A/he active IP Right Grant
- 2014-05-02 CL CL2014001156A patent/CL2014001156A1/es unknown
- 2014-05-16 ZA ZA2014/03574A patent/ZA201403574B/en unknown

Also Published As

Publication number	Publication date
BR112014010693A2 (pt)	2020-11-10
WO2013066352A1 (en)	2013-05-10
IL232385A (he)	2017-10-31
AU2011380509A1 (en)	2014-05-29
ZA201403574B (en)	2015-11-25
NZ624714A (en)	2016-01-29
IL232385A0 (he)	2014-06-30
MX354846B (es)	2018-03-22
SG11201402027PA (en)	2014-09-26
EP2775835A1 (en)	2014-09-17
EP2775835A4 (en)	2015-07-29
MX2014005399A (es)	2015-04-08
KR20140123927A (ko)	2014-10-23
AU2011380509B2 (en)	2016-05-19
KR101848122B1 (ko)	2018-04-11
CL2014001156A1 (es)	2015-01-16
CA2859689A1 (en)	2013-05-10
JP2014532759A (ja)	2014-12-08
CN104066323A (zh)	2014-09-24
CA2859689C (en)	2018-05-22

Publication	Publication Date	Title
JP6008974B2 (ja)	2016-10-19	痛風発赤の治療方法
US10137112B2 (en)	2018-11-27	Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent
JP6047172B2 (ja)	2016-12-21	患者部分集団における痛風の治療方法
JP6202633B2 (ja)	2017-09-27	ハロフェナートまたはハロフェン酸および第２の尿酸低下薬を用いる痛風に罹っている患者の高尿酸血症の治療方法
JP6368756B2 (ja)	2018-08-01	ハロフェナートまたはハロフェン酸および第２の尿酸低下薬を用いる痛風に罹っている患者の高尿酸血症の治療方法
AU2013245675B2 (en)	2017-02-09	Method for treating hyperuricemia in patients with gout using halofenate or halofenic acid and an anti-inflammatory agent
JP6192142B2 (ja)	2017-09-06	痛風発赤の治療方法
US20130302305A1 (en)	2013-11-14	Methods for Treating Gout in Patients Subpopulations

Legal Events

Date	Code	Title	Description
2014-11-05	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20141104
2014-11-05	A621	Written request for application examination	Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20141104
2015-09-09	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150908
2015-12-02	A601	Written request for extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20151202
2016-01-07	A601	Written request for extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20160107
2016-02-08	A601	Written request for extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20160208
2016-02-18	RD04	Notification of resignation of power of attorney	Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20160218
2016-03-07	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160307
2016-08-16	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160816
2016-09-29	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160929
2016-10-19	TRDD	Decision of grant or rejection written
2016-10-25	A01	Written decision to grant a patent or to grant a registration (utility model)	Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20161025
2016-11-24	A61	First payment of annual fees (during grant procedure)	Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20161118
2016-11-25	R150	Certificate of patent or registration of utility model	Ref document number: 6047172 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150
2017-04-04	S111	Request for change of ownership or part of ownership	Free format text: JAPANESE INTERMEDIATE CODE: R313114
2017-04-12	R350	Written notification of registration of transfer	Free format text: JAPANESE INTERMEDIATE CODE: R350
2019-11-25	LAPS	Cancellation because of no payment of annual fees